VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IMS 2022 | Optimal management of MGCS-related disorders

Nelson Leung, Mayo Clinic, Rochester, MN, comments on the management of monoclonal gammopathy of clinical significance (MGCS)-related disorders including monoclonal gammopathy-related keratopathy, monoclonal gammopathy of renal significance, Schnitzler syndrome, and scleromyxedema. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter